Literature DB >> 69600

[Isolation and characterization of an unknown, leucine-rich 3.1-S-alpha2-glycoprotein from human serum (author's transl)].

H Haupt, S Baudner.   

Abstract

This article describes the isolation and characterization of a previously unknown, leucine-rich 3.1S-alpha2-glycoprotein from human serum. The starting material was Supernatant II, which is a byproduct in the large-scale preparation of albumin and gamma-globulin by the ethacridine lactate/ammonium sulfate procedure. The purified protein is homogenous both in carrier-free and molecular-sieve electrophoresis. Its electrophoretic mobility indicates that it belongs to the alpha2-globulins. Isoelectric focussing splits it into 4 bands with isoelectric points between 3.8 and 4.1. In the ultracentrifuge it sediments in a single band at 3.1S. The molecular weight determined by equilibrium sedimentation is 49 600 +/- 4 000. Subunits were not detected. Chemical analysis reveals it to be a glycoprotein with a carbohydrate content of 23%. The amino acid content is unusual in that the leucine content is almost 17%, i.e. about every fifth amino acid is a leucine. The average concentration of the leucine-rich 3.1S-alpha2-glycoprotein in human serum was determined by a quantitative immunological method as 2.1 mg per 100 ml. The protein is not related to any of the previously known well characterized serum proteins.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 69600

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  44 in total

1.  Investigation of an albumin-enriched fraction of human serum and its albuminome.

Authors:  Rebekah L Gundry; Qin Fu; Christine A Jelinek; Jennifer E Van Eyk; Robert J Cotter
Journal:  Proteomics Clin Appl       Date:  2007-01-01       Impact factor: 3.494

Review 2.  Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.

Authors:  Weiwei Jiang; Xuhang Li
Journal:  Mol Diagn Ther       Date:  2015-06       Impact factor: 4.074

3.  LRG1 suppresses the migration and invasion of hepatocellular carcinoma cells.

Authors:  Yurong Zhang; Qin Luo; Ning Wang; Fangyuan Hu; Haojie Jin; Tianxiang Ge; Cun Wang; Wenxin Qin
Journal:  Med Oncol       Date:  2015-03-27       Impact factor: 3.064

4.  Autologous extracellular cytochrome c is an endogenous ligand for leucine-rich alpha2-glycoprotein and beta-type phospholipase A2 inhibitor.

Authors:  Ryoichi Shirai; Rikiya Gotou; Fumiyasu Hirano; Kiyoshi Ikeda; Seiji Inoue
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

5.  Stable knockdown of LRG1 by RNA interference inhibits growth and promotes apoptosis of glioblastoma cells in vitro and in vivo.

Authors:  Di Zhong; Siren Zhao; Guangxu He; Jinku Li; Yanbin Lang; Wei Ye; Yongli Li; Chuanlu Jiang; Xianfeng Li
Journal:  Tumour Biol       Date:  2015-01-15

6.  Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients.

Authors:  John D Andersen; Kristin Lm Boylan; Ronald Jemmerson; Melissa A Geller; Benjamin Misemer; Katherine M Harrington; Starchild Weivoda; Bruce A Witthuhn; Peter Argenta; Rachel Isaksson Vogel; Amy Pn Skubitz
Journal:  J Ovarian Res       Date:  2010-09-10       Impact factor: 4.234

7.  LRG-accelerated differentiation defines unique G-CSFR signaling pathways downstream of PU.1 and C/EBPepsilon that modulate neutrophil activation.

Authors:  Jing Ai; Lawrence J Druhan; Melissa G Hunter; Megan J Loveland; Belinda R Avalos
Journal:  J Leukoc Biol       Date:  2008-02-13       Impact factor: 4.962

8.  Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum.

Authors:  N Takahashi; Y Takahashi; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

9.  Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study.

Authors:  Shinichiro Shinzaki; Katsuyoshi Matsuoka; Hiroki Tanaka; Fuminao Takeshima; Shingo Kato; Takehiro Torisu; Yuki Ohta; Kenji Watanabe; Shiro Nakamura; Naoki Yoshimura; Taku Kobayashi; Akiko Shiotani; Fumihito Hirai; Sakiko Hiraoka; Mamoru Watanabe; Minoru Matsuura; Shohei Nishimoto; Shinta Mizuno; Hideki Iijima; Tetsuo Takehara; Tetsuji Naka; Takanori Kanai; Takayuki Matsumoto
Journal:  J Gastroenterol       Date:  2021-05-03       Impact factor: 7.527

10.  The Prognostic Value of Leucine-Rich α2 Glycoprotein 1 in Pediatric Spinal Cord Injury.

Authors:  Hong Ma; Fengshan Lu; Yueming Guo; Zhaoxiong Shen; Yuanzhen Chen
Journal:  Biomed Res Int       Date:  2021-07-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.